サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467888

婦人科健診市場レポート：タイプ、用途、エンドユーザー、地域別、2024～2032年

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
婦人科健診市場レポート：タイプ、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

婦人科健診の世界市場規模は2023年に292億米ドルに達しました。今後、IMARC Groupは、2032年には526億米ドルに達し、2024～2032年の間に6.6%の成長率（CAGR）を示すと予測しています。

婦人科健診は、女性患者のさまざまな生物学的・心理社会的状態の診断に役立ちます。性・膣の問題や妊娠合併症に対処し、骨粗鬆症、更年期障害、乳がんや子宮頸がんなどの脅威となる疾患の管理を支援します。生検、超音波検査、化学療法、磁気共鳴画像法（MRI）など、一連の高度な臨床検査、ツール、手技を駆使しています。現在、いくつかの医療診断センターは、女性に影響を及ぼすまれな病気や状態の診断と管理を強化するために、広範な臨床検査ソリューションを提供しています。

婦人科健診市場の動向：

女性の全体的な幸福に影響を与える健康問題の有病率の上昇は、市場にプラスの影響を与える主要要因の一つです。さらに、健康意識の高まりと早期診断の利点に関する意識の高まりが、世界中でポイントオブケア（POC）婦人科健診の需要を喚起しています。これとは別に、ストレスの多いライフスタイルやアルコール・薬剤摂取の増加による不妊率の上昇が、妊娠合併症に対処し、より健康的な生活を確保するための婦人科健診の必要性を高めています。さらに、更年期は心血管疾患や尿失禁を含む特定の病状の発症リスクを高める可能性があるため、50歳以上の女性人口の大幅な増加が市場の成長に寄与しています。これに加えて、いくつかの調査では、女性はホルモンの変化時にうつ病や不安症などの精神疾患を経験する可能性が高いという結論が出ています。このことは、女性のメンタルヘルスを改善するために多くの国の保健機関が行っているいくつかの取り組みと相まって、世界全体の市場成長を促進しています。

本レポートで扱う主要質問

  • 2023年の世界の婦人科健診市場規模は？
  • 2024～2032年にかけての世界の婦人科健診市場の成長率はどのくらいと予測されるか？
  • 婦人科健診の世界市場を牽引する主要因は？
  • COVID-19が世界の婦人科健診市場に与えた影響は？
  • 婦人科健診の世界市場のタイプ別区分は？
  • 婦人科健診の世界市場の用途別区分は？
  • 婦人科健診の世界市場のエンドユーザー別区分は？
  • 婦人科健診の世界市場の主要地域は？
  • 婦人科健診の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 婦人科健診の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 診断機器
    • 市場動向
    • 主要セグメント
      • 生検装置
      • 画像診断・モニタリング機器
      • 付属品と消耗品
    • 市場予測
  • 診断テスト
    • 市場動向
    • 主要セグメント
      • 乳がん検査
      • PAPスメア検査とHPV検査
      • 妊娠検査と排卵検査
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 乳がん
  • 感染症検査
  • 骨粗鬆症検査
  • 妊娠・不妊検査
  • 性感染症検査
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院・診断センター
  • 在宅医療

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Cardinal Health Inc.
    • Cook Group Incorporated
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hologic Inc.
    • Koninklijke Philips N.V.
    • Perkinelmer Inc.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players
目次
Product Code: SR112024A4956

The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

Diagnostic Devices

Biopsy Device

Imaging and Monitoring Devices

Accessories and Consumables

Diagnostic Tests

Breast Cancer Testing

PAP Smear and HPV Test

Pregnancy Testing and Ovulation Testing

Others

Breakup by Application:

Breast Cancer

Infectious Disease Testing

Osteoporosis Testing

Pregnancy and Fertility Testing

Sexually Transmitted Disease Testing

Others

Breakup by End User:

Hospital and Diagnostics Centers

Home Care

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global women's health diagnostics market in 2023?
  • 2. What is the expected growth rate of the global women's health diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global women's health diagnostics market?
  • 4. What has been the impact of COVID-19 on the global women's health diagnostics market?
  • 5. What is the breakup of the global women's health diagnostics market based on the type?
  • 6. What is the breakup of the global women's health diagnostics market based on the application?
  • 7. What is the breakup of the global women's health diagnostics market based on the end user?
  • 8. What are the key regions in the global women's health diagnostics market?
  • 9. Who are the key players/companies in the global women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cook Group Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 General Electric Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis